Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lipinski

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
American Journal of Respiratory and Critical Care Medicine|December 5, 2023
Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung DiseaseDavid N O'Dwyer, John S Kim, Shwu-Fan Ma, et al.
American Journal of Respiratory and Critical Care Medicine|May 19, 2026
Gut microbiota associate with disease severity and survival in idiopathic pulmonary fibrosisJohn S Kim, Abigail Loe, Shwu-Fan Ma, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosisYosuke Sakamachi, Emma Wiley, Alma Solis, et al.
Science Translational Medicine|June 3, 2026
Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and <i>TLR5</i> deficiency is associated with human IPFYosuke Sakamachi, Emma Wiley, Carol S Trempus, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
American Journal of Respiratory and Critical Care Medicine|December 5, 2023
Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung DiseaseDavid N O'Dwyer, John S Kim, Shwu-Fan Ma, et al.
American Journal of Respiratory and Critical Care Medicine|May 19, 2026
Gut microbiota associate with disease severity and survival in idiopathic pulmonary fibrosisJohn S Kim, Abigail Loe, Shwu-Fan Ma, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosisYosuke Sakamachi, Emma Wiley, Alma Solis, et al.
Science Translational Medicine|June 3, 2026
Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and <i>TLR5</i> deficiency is associated with human IPFYosuke Sakamachi, Emma Wiley, Carol S Trempus, et al.
Pageof 2